S.N. Kamath, currently serving as Chief Executive Officer (CEO) of Bliss GVS Pharma Limited, has been appointed as Managing Director (MD) of the company, effective upon approval of the special resolution by the shareholders.
S.N. Kamath began his career in Mumbai and entered the pharmaceutical industry through the export of anti-malarial drugs under GVS Labs. He later acquired Bliss Chemicals & Pharmaceuticals, which led to the creation of Bliss GVS Pharma Limited, where he is the promoter.
With over three decades of entrepreneurial leadership, Kamath has driven the company’s expansion into more than 60 international markets and overseen the development of multiple manufacturing facilities. He continues to play a pivotal role in strategic operations, product portfolio growth, and global market penetration for Bliss GVS Pharma.
